about
A candidate gene approach identifies an IL33 genetic variant as a novel genetic risk factor for GCAIdentification of the PTPN22 functional variant R620W as susceptibility genetic factor for giant cell arteritis.Treatment of polymyalgia rheumatica: a systematic review.A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility.Circulating soluble adhesion molecules in patients with giant cell arteritis. Correlation between soluble intercellular adhesion molecule-1 (sICAM-1) concentrations and disease activityEndothelial cells, antineutrophil cytoplasmic antibodies, and cytokines in the pathogenesis of systemic vasculitis.Single-organ gallbladder vasculitis: characterization and distinction from systemic vasculitis involving the gallbladder. An analysis of 61 patients.Relapses in patients with giant cell arteritis: prevalence, characteristics, and associated clinical findings in a longitudinally followed cohort of 106 patientsEffect of glucocorticoid treatment on computed tomography angiography detected large-vessel inflammation in giant-cell arteritis. A prospective, longitudinal studyDescription and Validation of Histological Patterns and Proposal of a Dynamic Model of Inflammatory Infiltration in Giant-cell ArteritisSingle-organ vasculitis.A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis.Antineutrophil cytoplasmic antibody-associated vasculitides and respiratory disease.Surgical interventions and local therapy for Wegener's granulomatosis.Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy.Disease Phenotype and Outcome Depending on the Age at Disease Onset in Patients Carrying the R92Q Low-Penetrance Variant in TNFRSF1A Gene.Diagnosis and classification of polyarteritis nodosa.Advances in the diagnosis of large vessel vasculitis.Clinical and genetic characterization of the autoinflammatory diseases diagnosed in an adult reference center.The Expanding Role of Imaging in Systemic Vasculitis.Prospective long term follow-up of a cohort of patients with giant cell arteritis screened for aortic structural damage (aneurysm or dilatation).DNA demethylation of inflammasome-associated genes is enhanced in patients with cryopyrin-associated periodic syndromes.Testicular vasculitis: findings differentiating isolated disease from systemic disease in 72 patients.Somatic NLRP3 mosaicism in Muckle-Wells syndrome. A genetic mechanism shared by different phenotypes of cryopyrin-associated periodic syndromes.Clinical relevance of persistently elevated circulating cytokines (tumor necrosis factor alpha and interleukin-6) in the long-term followup of patients with giant cell arteritis.Increased expression of the endothelin system in arterial lesions from patients with giant-cell arteritis: association between elevated plasma endothelin levels and the development of ischaemic events.Limited utility of rapamycin in severe, refractory Wegener's granulomatosis.Treatment with angiotensin II receptor blockers is associated with prolonged relapse-free survival, lower relapse rate, and corticosteroid-sparing effect in patients with giant cell arteritis.Development of aortic aneurysm/dilatation during the followup of patients with giant cell arteritis: a cross-sectional screening of fifty-four prospectively followed patients.Monogenic autoinflammatory diseases: General concepts and presentation in adult patients.Nasoseptal Perforation: from Etiology to Treatment.Endothelin-1 promotes vascular smooth muscle cell migration across the artery wall: a mechanism contributing to vascular remodelling and intimal hyperplasia in giant-cell arteritis.Changes in biomarkers after therapeutic intervention in temporal arteries cultured in Matrigel: a new model for preclinical studies in giant-cell arteritis.[Basic cardiopulmonary resuscitation program for high school students (PROCES). Results from the pilot program].Blocking interferon γ reduces expression of chemokines CXCL9, CXCL10 and CXCL11 and decreases macrophage infiltration in ex vivo cultured arteries from patients with giant cell arteritis.Positron emission tomography assessment of large vessel inflammation in patients with newly diagnosed, biopsy-proven giant cell arteritis: a prospective, case-control study.Large vessel involvement in biopsy-proven giant cell arteritis: prospective study in 40 newly diagnosed patients using CT angiography.Long-Term Outcomes of Patients With HCV-Associated Cryoglobulinemic Vasculitis After Virologic Cure.Eosinophilic granulomatosis with polyangitis (Churg-Strauss) and severe pericardial effusion.Association between increased CCL2 (MCP-1) expression in lesions and persistence of disease activity in giant-cell arteritis.
P50
Q28545058-48A66F93-8C6C-4FAE-A666-6E176C000674Q33741232-7E3E8D30-6E3C-44E3-8078-55A519E6A8CBQ35012044-492883AA-54A8-4ACF-A427-F17BEC978E0EQ35266391-FBC7E3A8-CF0A-4C48-9ECD-9489E1B22991Q35548461-F9D2FD59-BA8E-4DE0-8645-47DCC65C98BDQ35768673-A16AABA5-2D9E-4CA9-9626-4E0802E402D7Q36150847-40AB3D9B-078B-424F-90DE-1CD8DE116DC8Q36150929-E1F35C45-1F19-4215-8B7D-261697FCDE5BQ36152152-0BE99EDF-E795-431C-A859-887EA8E2FEF0Q36653502-E66D990A-0227-4392-9D21-23105C2722DFQ37087271-84B3421A-45A2-42D9-BCED-400FD5A0B80DQ37575470-611FE9DA-294F-47DD-AF88-5A8029332D50Q37609857-521DD569-73D5-4D89-A4D6-D4D6870163BEQ37632177-6D2A460D-2B3E-4997-9559-AF0A17F61A85Q37691169-38830841-6E88-43FB-83DD-3EDB26DDB3EFQ37721228-0A200355-02E7-43DF-A622-43702C566073Q38184079-E2F580AD-5B5E-4E68-B571-0AC9CFC1EDEEQ38268557-41387309-326E-43E4-9414-C905FF13A734Q38572205-815DAF1A-7A16-40BD-A7CB-8BDF32658209Q38980942-B5351B28-497E-44B1-A26C-0F8A5A9D6992Q39200766-5FC5765A-209B-40DD-89CB-09E4669A813CQ40097682-9B3F1F94-CBBD-4C7A-A2AD-3897DA0B1C9FQ40294137-777ADA9A-BE6A-438C-94C5-751B8B524426Q42632616-9FF78EB5-7970-40DB-9D31-5A74C6D4BDBCQ43035849-21BB2583-49BD-4504-A45C-EAB9E8F7B77DQ46086941-02F8EFE1-226F-4C45-B86B-8484212FA19DQ46243991-867B6EC8-08E6-4C58-9F83-3D67E47D6D87Q46710038-8C6D69DA-A94F-4B87-BF39-43E00E61E6E7Q46724783-92F632D3-86C8-480A-B7DF-EE9780A689A2Q47782740-FF40B307-B274-44A3-B963-64D7B9A7B9B4Q50194047-5BDF3083-BE55-44CD-A4B5-ABCCF23BDC59Q50948184-72DB6DD5-2101-446F-9968-AC24D4BFBB98Q51033475-201725EA-CCAD-425A-BB30-42996CBA8D4BQ52058920-510CBC99-9B5E-4F5E-B06D-2791C700BC85Q52893205-95D05A0C-89CA-4DC9-8C69-09AD473ADBD2Q53073312-AFF753D8-FA60-4876-A8AC-A6EC69A9D866Q53179293-964790F5-0C72-451E-8D0F-D6329DC1E16FQ53821067-AC48A228-1D5C-4FB8-BA13-5221DA243C8EQ54262748-C2B6F7B4-3F18-441B-8764-0698D6E22D7BQ54607726-230ED025-28FD-48BE-96F4-4E9C4039C479
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-2357-2015
@en
name
José Hernández-Rodríguez
@ast
José Hernández-Rodríguez
@en
José Hernández-Rodríguez
@es
José Hernández-Rodríguez
@nl
type
label
José Hernández-Rodríguez
@ast
José Hernández-Rodríguez
@en
José Hernández-Rodríguez
@es
José Hernández-Rodríguez
@nl
prefLabel
José Hernández-Rodríguez
@ast
José Hernández-Rodríguez
@en
José Hernández-Rodríguez
@es
José Hernández-Rodríguez
@nl
P106
P1153
7003408402
P21
P31
P496
0000-0002-2357-2015